Search Results - "Guimaraes, Francisco S."

Refine Results
  1. 1

    Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety‐related and substance abuse disorders by Lee, Jonathan L C, Bertoglio, Leandro J, Guimarães, Francisco S, Stevenson, Carl W

    Published in British journal of pharmacology (01-10-2017)
    “…Learning to associate cues or contexts with potential threats or rewards is adaptive and enhances survival. Both aversive and appetitive memories are therefore…”
    Get full text
    Journal Article
  2. 2

    The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling by Fogaça, Manoela V., Campos, Alline C., Coelho, Ludmila D., Duman, Ronald S., Guimarães, Francisco S.

    Published in Neuropharmacology (01-06-2018)
    “…Repeated injections of cannabidiol (CBD), the major non-psychotomimetic compound present in the Cannabis sativa plant, attenuate the anxiogenic effects induced…”
    Get full text
    Journal Article
  3. 3

    Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age by Crippa, José A, Guimarães, Francisco S, Campos, Alline C, Zuardi, Antonio W

    Published in Frontiers in immunology (21-09-2018)
    “…Among the many cannabinoids in the cannabis plant, cannabidiol (CBD) is a compound that does not produce the typical subjective effects of marijuana. The aim…”
    Get full text
    Journal Article
  4. 4

    Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test by Linares, Ila M, Zuardi, Antonio W, Pereira, Luis C, Queiroz, Regina H, Mechoulam, Raphael, Guimarães, Francisco S, Crippa, José A

    Published in Revista brasileira de psiquiatria (01-01-2019)
    “…Cannabidiol (CBD), one of the non-psychotomimetic compounds of Cannabis sativa, causes anxiolytic-like effects in animals, with typical bell-shaped…”
    Get full text
    Journal Article
  5. 5
  6. 6

    On Disruption of Fear Memory by Reconsolidation Blockade: Evidence from Cannabidiol Treatment by STERN, Cristina Aj, GAZARINI, Lucas, TAKAHASHI, Reinaldo N, GUIMARAES, Francisco S, BERTOGLIO, Leandro J

    Published in Neuropsychopharmacology (New York, N.Y.) (01-08-2012)
    “…The search for reconsolidation blockers may uncover clinically relevant drugs for disrupting memories of significant stressful life experiences, such as those…”
    Get full text
    Journal Article
  7. 7

    Cannabidiol Induces Rapid and Sustained Antidepressant-Like Effects Through Increased BDNF Signaling and Synaptogenesis in the Prefrontal Cortex by Sales, Amanda J., Fogaça, Manoela V., Sartim, Ariandra G., Pereira, Vitor S., Wegener, Gregers, Guimarães, Francisco S., Joca, Sâmia R. L.

    Published in Molecular neurobiology (01-02-2019)
    “…Currently available antidepressants have a substantial time lag to induce therapeutic response and a relatively low efficacy. The development of drugs that…”
    Get full text
    Journal Article
  8. 8

    Animal models of anxiety disorders and stress by Campos, Alline C, Fogaça, Manoela V, Aguiar, Daniele C, Guimarães, Francisco S

    Published in Revista brasileira de psiquiatria (2013)
    “…Anxiety and stress-related disorders are severe psychiatric conditions that affect performance in daily tasks and represent a high cost to public health. The…”
    Get full text
    Journal Article
  9. 9

    Antidepressant‐like effect induced by systemic and intra‐hippocampal administration of DNA methylation inhibitors by Sales, Amanda J, Biojone, Caroline, Terceti, Mateus S, Guimarães, Francisco S, Gomes, Marcus VM, Joca, Sâmia RL

    Published in British journal of pharmacology (01-11-2011)
    “…BACKGROUND AND PURPOSE Epigenetic modifications are thought to play an important role in the neurobiology of depression. Antidepressant treatment induces…”
    Get full text
    Journal Article
  10. 10

    Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders by Campos, Alline C, Fogaça, Manoela V, Scarante, Franciele F, Joca, Sâmia R L, Sales, Amanda J, Gomes, Felipe V, Sonego, Andreza B, Rodrigues, Naielly S, Galve-Roperh, Ismael, Guimarães, Francisco S

    Published in Frontiers in pharmacology (23-05-2017)
    “…Beneficial effects of cannabidiol (CBD) have been described for a wide range of psychiatric disorders, including anxiety, psychosis, and depression. The…”
    Get full text
    Journal Article
  11. 11

    Cannabidiol prevents haloperidol-induced vacuos chewing movements and inflammatory changes in mice via PPARγ receptors by Sonego, Andreza B., Prado, Douglas S., Vale, Gabriel T., Sepulveda-Diaz, Julia E., Cunha, Thiago M., Tirapelli, Carlos R., Del Bel, Elaine A., Raisman-Vozari, Rita, Guimarães, Francisco S.

    Published in Brain, behavior, and immunity (01-11-2018)
    “…•CBD prevented haloperidol-induced orofacial dyskinesia and inflammatory changes.•CBD reduced microglial activation and oxidative stress stimulated by LPS in…”
    Get full text
    Journal Article
  12. 12

    "NO" Time in Fear Response: Possible Implication of Nitric-Oxide-Related Mechanisms in PTSD by Fronza, Mariana G, Ferreira, Bruna F, Pavan-Silva, Isabela, Guimarães, Francisco S, Lisboa, Sabrina F

    Published in Molecules (Basel, Switzerland) (01-01-2024)
    “…Post-traumatic stress disorder (PTSD) is a psychiatric condition characterized by persistent fear responses and altered neurotransmitter functioning due to…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials by Dos Santos, Rafael G, Guimarães, Francisco S, Crippa, José Alexandre S, Hallak, Jaime E C, Rossi, Giordano Novak, Rocha, Juliana Mendes, Zuardi, Antônio W

    “…Recent trials using cannabidiol (CBD) have shown that most acute and prolonged adverse effects of CBD are mild to moderate, with rare serious adverse effects…”
    Get more information
    Journal Article
  15. 15

    A time‐dependent contribution of hippocampal CB1, CB2 and PPARγ receptors to cannabidiol‐induced disruption of fear memory consolidation by Raymundi, Ana Maria, Silva, Thiago R., Zampronio, Aleksander R., Guimarães, Francisco S., Bertoglio, Leandro J., Stern, Cristina A.J.

    Published in British journal of pharmacology (01-02-2020)
    “…Background and Purpose In preclinical studies, cannabidiol (CBD) mitigates fear memories by facilitating their extinction or interfering with their…”
    Get full text
    Journal Article
  16. 16

    Chronic cannabidiol exposure promotes functional impairment in sexual behavior and fertility of male mice by Carvalho, Renata K., Souza, Maingredy R., Santos, Monaliza L., Guimarães, Francisco S., Pobbe, Roger Luís H., Andersen, Monica L., Mazaro-Costa, Renata

    Published in Reproductive toxicology (Elmsford, N.Y.) (01-10-2018)
    “…•CBD has biphasic effects on male copulation.•CBD negatively affected the fertilization rate and the number of litters.•The antifertility properties indicate…”
    Get full text
    Journal Article
  17. 17

    Cannabidiol attenuates prepulse inhibition disruption by facilitating TRPV1 and 5-HT1A receptor-mediated neurotransmission by Pedrazzi, João F.C., Silva-Amaral, Danyelle, Issy, Ana C., Gomes, Felipe V., Crippa, José A., Guimarães, Francisco S., Del Bel, Elaine

    Published in Pharmacology, biochemistry and behavior (01-12-2024)
    “…Individuals with schizophrenia (SCZ) often present sensorimotor gating impairments that can be investigated by the prepulse inhibition test (PPI). PPI…”
    Get full text
    Journal Article
  18. 18

    Hemopressin as a breakthrough for the cannabinoid field by Heimann, Andrea S., Dale, Camila S., Guimarães, Francisco S., Reis, Ricardo A.M., Navon, Ami, Shmuelov, Michal A., Rioli, Vanessa, Gomes, Ivone, Devi, Lakshmi L., Ferro, Emer S.

    Published in Neuropharmacology (01-02-2021)
    “…Hemopressin (PVNFKFLSH in rats, and PVNFKLLSH in humans and mice), a fragment derived from the α-chain of hemoglobin, was the first peptide described to have…”
    Get full text
    Journal Article
  19. 19

    Cannabidiol Regulation of Learned Fear: Implications for Treating Anxiety-Related Disorders by Jurkus, Regimantas, Day, Harriet L L, Guimarães, Francisco S, Lee, Jonathan L C, Bertoglio, Leandro J, Stevenson, Carl W

    Published in Frontiers in pharmacology (24-11-2016)
    “…Anxiety and trauma-related disorders are psychiatric diseases with a lifetime prevalence of up to 25%. Phobias and post-traumatic stress disorder (PTSD) are…”
    Get full text
    Journal Article
  20. 20

    Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-HT1A receptor activation in mice by Gomes, Felipe V., Del Bel, Elaine A., Guimarães, Francisco S.

    “…Cannabidiol (CBD) is a non-psychotomimetic compound from Cannabis sativa plant that produces antipsychotic effects in rodents and humans. It also reverses…”
    Get full text
    Journal Article